Development of a therapeutic chaperone against Alpha-1 anti-trypsin deficiency
People
(Responsible)
Additional information
Start date
01.05.2023
End date
30.04.2026
Duration
36 Months
Funding sources
Status
Active
Category
European and International Programmes /
Eurostars
